A detailed history of Kula Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 1,676 shares of CRL stock, worth $312,825. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,676
Previous 2,130 21.31%
Holding current value
$312,825
Previous $464 Million 27.12%
% of portfolio
0.08%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $87,118 - $118,003
-454 Reduced 21.31%
1,676 $338 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $419,844 - $532,649
2,130 New
2,130 $464 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.